Artelo Biosciences, Inc. (ARTL)

Nasdaq: ARTL · Pharmaceutical Preparations · Solana Beach, CA · filing with the SEC since 2014

Grade4.6

◀ Past 4.6● Present 4.3▶ Future 4.8

Overview Business Financials Grade Forecast Sentiment Ownership People Filings Patents Chart

Income statement, as filed

In US dollars (USD), as filed; per-share figures in US dollars; share counts. The fiscal year ends in December.

Income statement, by fiscal year, newest first
Fiscal year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Aug 31, 2021	Aug 31, 2020	Aug 31, 2019	Aug 31, 2018	Aug 31, 2017
Report filed	Feb 24, 2026	Mar 3, 2025	Mar 25, 2024	Mar 31, 2023	Mar 21, 2022	Nov 29, 2021	Nov 4, 2020	Nov 25, 2019	Nov 29, 2018	Nov 29, 2017
Research and development	5,423,000	5,993,000	5,696,000	4,324,000	3,784,000	2,839,000	1,919,000^r	1,091,992	1,249,854	·
General and administrative	5,981,000	4,115,000	4,234,000	5,963,000	5,633,000	4,602,000^r	1,789,000^r	952,334	508,278	110,865^r
Total operating expenses	11,404,000	10,108,000	9,930,000	10,287,000	9,417,000	7,441,000	4,686,000^r	3,209,531	2,343,491	232,789
Operating income	-11,404,000	-10,108,000	-9,930,000	-10,287,000	-9,417,000	-7,441,000	-4,686,000^r	-3,209,531	-2,343,491	-232,789
Interest expense	194,000	0	0	5,000	·	0	·	·	·	2,100
Total non-operating income (expense)	-1,475,000	282,000	641,000	204,000	10,000	4,000	31,000^r	1,037,355	·	-2,100
Income tax expense	0	0	0	0	0	0	0	0	0	0
Net income including non-controlling interests	·	-9,826,000	-9,289,000	10,083,000	·	7,437,000	·	·	·	·
Net income	-12,879,000	-9,826,000	-9,289,000	-10,083,000	-9,407,000	-7,437,000	-4,655,000^r	-2,172,176	-2,343,491	-234,889
Earnings per share, basic	·	·	·	·	·	·	·	-6.00^b	-11.04^b	·
Earnings per share, diluted	-12.52	-18.30^r	-18.84^b	·	·	·	·	-8.76^b	-11.04^b	·
Earnings per share, basic and diluted	·	·	·	·	·	-2.40^b	-7.56^b	-6.00^b	-1.38^b	-0.18^b
Weighted average shares, basic	·	·	·	·	·	·	·	362,078^b	212,921^b	·
Weighted average shares, diluted	1,029,000	537,000^r	493,333^b	·	·	·	·	362,078^b	212,921^rb	321,217^b
Weighted average shares, basic and diluted	·	·	·	·	·	3,112,568,500^b	617,941,667^rb	362,078^b	1,703,370^b	1,455,401^b

As filed with the SEC, each figure from the newest report that carries it, and linked to it. Nothing here is computed.Share counts and per-share figures are on the newest report's basis, after the 1-for-6 reverse split.A dot is a line not tagged for that period. ^r restated by the company in a later report; ^b a share figure put on the newest basis or filed in the wrong unit. Hover a figure for its filing and note.

What each line is, and the XBRL concept behind it

Research and development spent on inventing what it sells nextus-gaap:ResearchAndDevelopmentExpense

General and administrative the cost of running the company itselfus-gaap:GeneralAndAdministrativeExpense

Total operating expenses the running costs togetherus-gaap:OperatingExpenses

Operating income profit from running the business, before interest and taxus-gaap:OperatingIncomeLoss

Interest expense what its borrowing costus-gaap:InterestExpense

Total non-operating income (expense) everything outside the business, togetherus-gaap:NonoperatingIncomeExpense

Income tax expense tax charged on the period's profitus-gaap:IncomeTaxExpenseBenefit

Net income including non-controlling interests the whole group's profit, minority holders' share includedus-gaap:ProfitLoss

Net income the profit or loss that belongs to the company's shareholdersus-gaap:NetIncomeLoss

Earnings per share, basic net income per share outstandingus-gaap:EarningsPerShareBasic

Earnings per share, diluted net income per share, counting every share that could be issuedus-gaap:EarningsPerShareDiluted

Earnings per share, basic and diluted net income per share, where both counts are the sameus-gaap:EarningsPerShareBasicAndDiluted

Weighted average shares, basic the average count of shares outstandingus-gaap:WeightedAverageNumberOfSharesOutstandingBasic

Weighted average shares, diluted the average count with every share that could be issuedus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Weighted average shares, basic and diluted the average count, where both counts are the sameus-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted

SI Assistanton ARTL · research, not advice